Furthermore, it would have been interesting to determine the AKT mutation status of the clinical samples and evaluate the correlation with clinical outcome, however, genotyping of metastatic breast cancers has just recently become available at our hospital and only on selected patients. The gene discussed is AKT1; the disease is breast cancer.